Structural and biological studies on bacterial nitric oxide synthase inhibitors

被引：39

作者：

Holden, Jeffrey K. ^{[1
,2
,3
]}

Li, Huiying ^{[1
,2
,3
]}

Jing, Qing ^{[4
,5
]}

Kang, Soosung ^{[4
,5
]}

Richo, Jerry ^{[1
,2
,3
]}

Silverman, Richard B. ^{[4
,5
]}

Poulos, Thomas L. ^{[4
,5
]}

机构：

[1] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA

[2] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA

[3] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA

[4] Northwestern Univ, Ctr Mol Innovat & Drug Discovery, Chem Life Proc Inst, Dept Chem, Evanston, IL 60208 USA

[5] Northwestern Univ, Ctr Mol Innovat & Drug Discovery, Chem Life Proc Inst, Dept Mol Biosci, Evanston, IL 60208 USA

来源：

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 2013年 / 110卷 / 45期

基金：

美国国家卫生研究院;

关键词：

crystallography; antibiotics; RATIONAL PROTEIN CRYSTALLIZATION; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ANTIBIOTICS; NITRATION; MECHANISM; MODE;

D O I：

10.1073/pnas.1314080110

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Nitric oxide (NO) produced by bacterial NOS functions as a cytoprotective agent against oxidative stress in Staphylococcus aureus, Bacillus anthracis, and Bacillus subtilis. The screening of several NOS- selective inhibitors uncovered two inhibitors with potential antimicrobial properties. These two compounds impede the growth of B. subtilis under oxidative stress, and crystal structures show that each compound exhibits a unique binding mode. Both compounds serve as excellent leads for the future development of antimicrobials against bacterial NOS- containing bacteria.

引用

页码：18127 / 18131

页数：5

共 50 条

[1] QSAR Studies of Nitric Oxide Synthase Inhibitors
Tsopka, Ioanna-Chrysoula
Hadjipavlou-Litina, Dimitra
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2023, 23 (29) : 2723 - 2734
[2] Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies
Maccallini, Cristina
Montagnani, Monica
Paciotti, Roberto
Ammazzalorso, Alessandra
De Filippis, Barbara
Di Matteo, Mauro
Di Silvestre, Sara
Fantacuzzi, Marialuigia
Giampietro, Letizia
Potenza, Maria A.
Re, Nazzareno
Pandolfi, Assunta
Amoroso, Rosa
ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (06): : 635 - 640
[3] Nitric oxide synthase inhibitors
不详
EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (10) : 1207 - 1210
[4] Nitric oxide synthase inhibitors
Macdonald, JE
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 31, 1996, 31 : 221 - 230
[5] Nitric oxide synthase inhibitors
Lloyd, AW
DRUG DISCOVERY TODAY, 1996, 1 (08) : 352 - 352
[6] Nitric oxide synthase inhibitors
Lloyd, AW
DRUG DISCOVERY TODAY, 2000, 5 (12) : 570 - 570
[7] Targeting Bacterial Nitric Oxide Synthase with Aminoquinoline-Based Inhibitors
Holden, Jeffrey K.
Lewis, Matthew C.
Cinelli, Maris A.
Abdullatif, Ziad
Pensa, Anthony V.
Silverman, Richard B.
Poulos, Thomas L.
BIOCHEMISTRY, 2016, 55 (39) : 5587 - 5594
[8] Structure-Based Design of Bacterial Nitric Oxide Synthase Inhibitors
Holden, Jeffrey K.
Kang, Soosung
Hollingsworth, Scott A.
Li, Huiying
Lim, Nathan
Chen, Steven
Huang, He
Xue, Fengtian
Tang, Wei
Silverman, Richard B.
Poulos, Thomas L.
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (02) : 994 - 1004
[9] Effects of three inhibitors of nitric oxide synthase on host resistance to bacterial infection
Fukatsu, K
Saito, H
Fukushima, R
Lin, MT
Inoue, T
Inaba, T
Furukawa, S
Han, L
Muto, T
INFLAMMATION RESEARCH, 1996, 45 (03) : 109 - 112
[10] Nitric Oxide Synthase Inhibitors as Antidepressants
Wegener, Gregers
Volke, Vallo
PHARMACEUTICALS, 2010, 3 (01): : 273 - 299

← 1 2 3 4 5 →